Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR7 | P34969 | 2/20 | 0.48 |
| ▸ | GAA | P10253 | 4/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.40 |
| ▸ | CA1 | P00915 | 2/20 | 0.38 |
| ▸ | CA2 | P00918 | 2/20 | 0.38 |
| ▸ | CA9 | Q16790 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | KCNH3 | Q9ULD8 | 1/20 | 0.35 |
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | HTT | P42858 | 2/20 | 0.34 |
| ▸ | F2 | P00734 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7626245 | 0.86 | GAA (0.44) | HTR7GAATDP1KMT2AMEN1 | |
| SCHEMBL8433636 | 0.85 | ALDH1A1 (0.46) | HTR7GAATDP1KMT2AMEN1 | |
| SCHEMBL5088409 | 0.81 | GAA (0.52) | HTR7GAATDP1KMT2AMEN1 | |
| SCHEMBL7713854 | 0.80 | GAA (0.53) | HTR7GAATDP1KMT2AMEN1 | |
| SCHEMBL30076244 | 0.80 | GAA (0.53) | HTR7GAATDP1KMT2AMEN1 | |
| SCHEMBL10572863 | 0.77 | HRH4 (0.42) | KMT2ACA1CA2CA9KCNH3 | |
| SCHEMBL8464395 | 0.76 | KMT2A (0.46) | HTR7GAAKMT2AMEN1CYP1A2 | |
| SCHEMBL2371884 | 0.76 | GAA (0.48) | HTR7GAATDP1KMT2AMEN1 | |
| SCHEMBL8854525 | 0.73 | KCNH3 (0.49) | HTR7ALDH1A1KCNH3LMNAHTT | |
| SCHEMBL10572859 | 0.72 | HTR7 (0.42) | HTR7KMT2ACA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0568635-A1 | IMPROVED GLYPHOSATE FORMULATIONS. | MONSANTO CO (US) | 1993-11-10 | — | — | EP | claimed |
| WO-1992012637-A1 | IMPROVED GLYPHOSATE FORMULATIONS | MONSANTO COMPANY (US) | 1992-08-06 | — | — | WO | claimed |
| EP-2770827-B1 | COMPOSITION, METHOD FOR PRODUCING THE COMPOSITION, AND PHYTOSANITARY FORMULATION CONTAINING SAME | RHODIA OPERATIONS (FR) | 2019-07-17 | — | — | EP | disclosed |
| EP-2547199-B1 | NOVEL USES OF ESTERAMIDE COMPOUNDS | RHODIA OPERATIONS (FR) | 2018-05-16 | — | — | EP | disclosed |
| EP-2547651-B1 | ESTERAMIDE COMPOUNDS, METHODS FOR PREPARING SAME, AND USES THEREOF | RHODIA OPERATIONS (FR) | 2016-10-19 | — | — | EP | disclosed |
| US-9420780-B2 | Composition, method for producing the composition, and phytosanitary formulation containing same | RHODIA OPERATIONS (FR) | 2016-08-23 | — | — | US | disclosed |
| EP-2961739-A2 | FURFURAL DERIVATIVES AS A VEHICLE | Rhodia Operations (FR) | 2016-01-06 | — | — | EP | disclosed |
| US-9090538-B2 | Uses of esteramide compounds | RHODIA OPERATIONS (FR) | 2015-07-28 | — | — | US | disclosed |
| US-8981148-B2 | Esteramide compounds, methods for preparing same, and uses thereof | RHODIA OPERATIONS (FR) | 2015-03-17 | — | — | US | disclosed |
| US-20150013032-A1 | USE OF MIXED DUPLEX OLIGONUCLEOTIDES TO EFFECT LOCALIZED GENETIC CHANGES IN PLANTS | CIBUS US LLC (US) | 2015-01-08 | — | — | US | disclosed |
| US-20140256554-A1 | COMPOSITION, METHOD FOR PRODUCING THE COMPOSITION, AND PHYTOSANITARY FORMULATION CONTAINING SAME | RHODIA OPERATIONS (FR) | 2014-09-11 | — | — | US | disclosed |
| EP-1218524-A2 | COMPOSITIONS AND METHODS FOR PLANT GENETIC MODIFICATION | Valigen Inc. (US) | 2002-07-03 | — | — | EP | disclosed |
| WO-2001025460-A2 | COMPOSITIONS AND METHODS FOR PLANT GENETIC MODIFICATION | VALIGEN, INC. (US) | 2001-04-12 | — | — | WO | disclosed |
| US-5958835-A | Surfactant compositions | NOVARTIS CORPORATION (FORMERLY CIBA-GEIGY CORPORATION) (US) | 1999-09-28 | — | — | US | disclosed |
| US-5945082-A | HERBICIDES, INSECTICIDES, FLAME RETARDANTS, PLASTICIZERS; CYANATION, SALT FORMATION, PHOSPHONATION, PHOSPHATING | MONSANTO COMPANY (US) | 1999-08-31 | — | — | US | disclosed |
| US-5446014-A | A nonsettling solution comprising a quaternary ammonium compound paraquat dichloride as stabilizers | RHONE-POULENC CHIMIE (FR) | 1995-08-29 | — | — | US | disclosed |
| US-4912245-A | Surfactant composition | RHONE-POULENC CHIMIE (FR) | 1990-03-27 | — | — | US | disclosed |
| US-4867972-A | Novel surface-active compositions containing polydicarboxylic acid polymer and surfactant | RHONE-POULENC SPECIALITES CHIMIQUES (FR) | 1989-09-19 | — | — | US | disclosed |
| EP-0201417-B1 | SURFACTANT COMPOSITION, PROCESS FOR ITS PREPARATION AND ITS USE | RHONE-POULENC CHIMIE (FR) | 1988-09-14 | — | — | EP | disclosed |
| EP-0201417-A1 | Surfactant composition, process for its preparation and its use | RHONE-POULENC CHIMIE (FR) | 1986-11-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140256554-A1 | COMPOSITION, METHOD FOR PRODUCING THE COMPOSITION, AND PHYTOSANITARY FORMULATION CONTAINING SAME | C1R, CNR2, SRR | HTR7 701/4885GAA 2235/4885TDP1 4386/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.